Today more than ever, the demand for health and services, technological innovations, changes in the epidemiological
framework, and social, political and economic pressures are at the root of the growing complexity of modern healthcare, and clinical research and innovation are necessary elements to guarantee a cutting-edge NHS. For health authorities
conducting clinical trials, this translates into the mission of combining clinical inpatient and outpatient services with
specific biomedical scientific research activities, where the emphasis is on the contextuality and complementarity
between these dimensions. The results of the research conducted in 2024 by ALTEMS and FIASO on The role of General Managers (DGs) in clinical research highlight several areas for improvement and provide insights for a
more efficient and inclusive future, in which up-to-date regulations, flexible organisational models, state-of-the-art
technologies and close collaboration between stakeholders can make a difference.
Once again, the role of DGs emerges as a key factor in addressing these challenges and driving change towards a
more modern and efficient healthcare system.